Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trialKausik K Ray, Marie T. Baccara‐Dinet, Deepak L. Bhatt et al.|The Lancet Diabetes & Endocrinology|2019Cited by 330
Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trialDeepak L. Bhatt, Mark Napoli, Philippe Gabríel Steg et al.|The Lancet|2019Cited by 212